Infusion Prescribers

Welcome! Here you can find resources for healthcare providers ordering COVID-19 antibody infusions.

COVID-19 Antibody Therapy Locator

Prescribers can use our COVID-19 Locator Tool to find infusion centers administering COVID-19 antibody therapies. Please note you area able to search between 5 and 100 miles from your chosen zip code or city and state.

Important Update Regarding Bamlanivimab + Etesevimab Distribution

Important Notice: On June 25, 2021, the FDA is immediately pausing all distribution of bamlanivimab and etesevimab together and etesevimab alone (to pair with existing supply of bamlanivimab at a facility for use under EUA 094) on a national basis until further notice.

Important Notice: On April 16, 2021, the FDA revoked emergency use authorization for bamlanivimab monotherapy due to the increased prevalence of SARS-CoV-2 variants that are expected to be resistant to bamlanivimab administered alone. This change comes at the request of the manufacturer, Eli Lilly, due to the availability of more efficacious monoclonal antibody therapies, and is not related to any adverse events or safety issues.  For more information, see the FDA’s Letter of Revocation, and Frequently Asked Questions on the Revocation of the Emergency Use Authorization for Bamlanivimab Administered Alone.

Casirivimab + Imdevimab Order Set Tile
Casirivimab + Imdevimab Infusion Order Set

Prescription for Casirivimab + Imdevimab infusion therapy. (Updated 6-10-2021)

Locator Prescribers
Prescribing a COVID-19 Monoclonal Antibody?

Here’s how to find a treatment site:

Indications Checklist Tile
Indications Checklist

(Updated 5-20-21) This checklist is intended to help determine if treatment with COVID-19 antibody therapies are indicated in accordance with the Emergency Use Authorization (EUA).

If COVID-19 antibody therapies are not indicated, the checklist can be included in the medical record to document the clinical decision-making process.

If COVID-19 antibody therapies are indicated, the checklist can accompany the medication order to document eligibility criteria and support medical necessity. Please note: individual infusion site documentation requirements may vary. 

COVID-19 Referral Checklist Tile
COVID-19 Antibody Therapeutics Referral Checklist

Overview of necessary steps to refer a patient for COVID-19 antibody therapies. Please note: Individual infusion site documentation requirements may vary. (Updated 1-22-21) 

-Infusion sites of care are encouraged to download and modify this checklist to create a custom checklist including any unique, site-specific requirements.

Preparing for Infusion Tile
Preparing for a COVID Infusion

A helpful guide to provide and review with patients to help answer questions about how to prepare for their infusion.

Locating Sites
Locating Sites for COVID-19 Antibody Treatments

Use these resources to identify sites of care administering COVID-19 antibody therapies.

MedWatch Tile
Report an adverse event to MedWatch

Providers must report on all serious adverse events and medication errors potentially related to bamlanivimab.

Eli Lilly Playbook
Eli Lilly Bamlanivimab Playbook

NICA collaborated with Eli Lilly to develop this playbook with in-depth information about bamlanivimab

Regeneron Casirivimab + Imdevimab Emergency Use Authorization (EUA) Guidebook

NICA collaborated with Regeneron to develop this playbook with in-depth information about Casirivimab + Imdevimab

Log in with your credentials

Forgot your details?